| Date Filed | Type | Description |
| 05/26/2023 |
4
| Aurentz Vincent (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
| 05/31/2022 |
4
| Aurentz Vincent (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 12,367 options to buy
@ $4.4, valued at
$54.4k
|
|
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 21,462 shares
@ $0 |
|
| 09/14/2021 |
4
| Aurentz Vincent (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.|
Txns:
| Granted 12,367 options to buy
@ $9.1, valued at
$112.5k
Granted 7,214 options to buy
@ $9.1, valued at
$65.6k
|
|
| 03/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Sold 25,000 shares
@ $65.0009, valued at
$1.6M
Exercised 10,000 options to buy
@ $17.1, valued at
$171k
Exercised 10,000 options to buy
@ $14.6, valued at
$146k
Exercised 5,000 options to buy
@ $35.6, valued at
$178k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Sold 9,000 shares
@ $50, valued at
$450k
|
|
| 10/16/2019 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Exercised 9,000 options to buy
@ $0 |
|
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2019 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 75,000 options to buy
@ $40.94, valued at
$3.1M
Granted 18,000 options to buy
@ $0 |
|
| 01/22/2018 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 130,000 options to buy
@ $35.6, valued at
$4.6M
|
|
| 02/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/15/2016 |
4
| Aurentz Vincent (Executive VP and CBO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 800,000 options to buy
@ $1.71, valued at
$1.4M
|
|
| 08/15/2016 |
3
| Aurentz Vincent (Executive VP and CBO) has filed a Form 3 on ARENA PHARMACEUTICALS INC |
| 05/31/2016 |
4
| Aurentz Vincent (Chief Business Officer) has filed a Form 4 on EPIRUS Biopharmaceuticals, Inc.|
Txns:
| Granted 230,000 restricted stock units
@ $0 |
|